GetPriceCoin logo GetPriceCoin logo
Real-World Evidence Crypto Coin Rank 4000
Website
N/A

Real-World Evidence
Real-World Evidence
RWE Coin Values RWE

Real-World Evidence valuesUSD Price
$ 0.0000

Real-World Evidence BTC Price
0.00000000

Real-World Evidence 24h Vol
$ 0

Real-World Evidence Market Cap
$ 0

24h Vol
1 0 BTC
1 H
0 %
24 H
0 %
7 d
0 %
Today Real-World Evidence price in US dollars is currently 0.0000 USD , and if converted to Bitcoin is 0.00000000 BTC . A total of 0 coin's are currently circulating in the Market. Real-World Evidence prices are currently experiencing a change of 0 %, check all cryptocurrency. Over the past 24 hours 0.000 M US dollars Real-World Evidence has been traded on Crypto Exchanges. Get Real-World Evidence's progress by adding it to your favourites and creating a free portfolio if you wish.
Full Name
Real-World Evidence
Symbol
RWE
Algorithm
ETH Token
BTC Price
0.00000000 BTC
BTC Market
0 BTC
BTC 24h Vol
0 BTC
Total Coins Mined
0 RWE
1h
0 %
24h
0 %
7d
0 %
Description

Real-World Evidence Crypto ICO Description

Embleema’s blockchain network offers a novel way to put patients at the center of clinical research by letting them own their health data, disrupting the slow, costly, manual and opaque process by which low-quality health data is currently collected by pharmaceutical companies through Contrat Research Organisation, to monitor the efficacy of new investigational drugs.

Embleema’s next building block is a Real-World Evidence (RWE) marketplace allowing patients to receive treatments and to connect with research. Sharing continuous, individual-patient level data will allow better monitoring of drugs in real-life and accelerate drug availability to patients.

Technology

Real-World Evidence Crypto Technology

Sorry, detailed technology about Real-World Evidence is not currently available

Features

Real-World Evidence Crypto Features

Sorry, detailed features about Real-World Evidence is not currently available

ICO Status

Real-World Evidence ICO Details

ICO Status
Ongoing
Token Supply
500000000
Start Date
2018-10-10
End Date
2019-03-31
Fund Raised (BTC)
N/A
Fund Raised (USD)
N/A
Start Price (USD)
0.1734
Security Audit Company
N/A
ICO Legal Form
Corporation
ICO Jurisdiction
France
Legal Advisers
N/A
White Paper

Embleema’s blockchain network offers a novel way to put patients at the center of clinical research by letting them own their health data, disrupting the slow, costly, manual and opaque process by which low-quality health data is currently collected by pharmaceutical companies through Contrat Research Organisation, to monitor the efficacy of new investigational drugs.

Embleema’s next building block is a Real-World Evidence (RWE) marketplace allowing patients to receive treatments and to connect with research. Sharing continuous, individual-patient level data will allow better monitoring of drugs in real-life and accelerate drug availability to patients.

Embleema ICO began on October 10, 2018. The ICO token supply represents 30% of the total token supply, so there is a total of 150,000,000 RWD tokens available, for 0.1734 each. The ICO funding target is 15,000,000 RWD, the funding cap is 150,000,000 RWD and is expected to end on March 31, 2019 or when the funding cap is reached.

Team:

  • Robert Chu: CEO.  
  • Alexis Normand: Head of Blockchain Consortium.  
  • Nicolas Schmidt: Chief Product Officer. 
  • Prashant Khambekar, Ph.D.: Chief Blockchain Development Executive. 

Token Reserve Split (70%):

  • 48% Compensation of Data Owners storing Health Records;
  • 15% Embleema Founders & Advisors;
  • 7% Marketing & Community Development Fund

Embleema ICO features a bounty campaign.


Get Crypto Newsletter
Read the Disclaimer : All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured from third party sources. We make no warranties of any kind in relation to our content, including but not limited to accuracy and updatedness. No part of the content that we provide constitutes financial advice, legal advice or any other form of advice meant for your specific reliance for any purpose. Any use or reliance on our content is solely at your own risk and discretion. You should conduct your own research, review, analyse and verify our content before relying on them. Trading is a highly risky activity that can lead to major losses, please therefore consult your financial advisor before making any decision. No content on our Site is meant to be a solicitation or offer